Navigation Links
Digital Healthcare Wins FDA Approval for Retasure
Date:9/22/2007

Unique Retinal Imaging System Allows Primary Care Physicians to Capture

Digital Retinal Images

WAKE FOREST, N.C., Sept. 19 /PRNewswire/ -- Digital Healthcare Inc., a retinal risk assessment and disease management company based in Wake Forest, NC, announced today that it has won approval from the U.S. Food and Drug Administration to pre-market its Retasure retinal risk assessment system and its iP(R) technology platform.

Retasure is a simple, affordable solution that allows primary care physicians to capture digital images of diabetic patients' retinas in a non-invasive procedure that takes just a few minutes. The images are then transmitted over a secure, HIPPA compliant network to a board certified ophthalmologist at an accredited reading center for examination and assessment. Results are returned to the primary care physician within 72 hours.

Digital Healthcare has already announced several major contracts with primary diabetes care and ophthalmology providers in several states and is now planning general availability of the Retasure system throughout the United States. Retasure was introduced in the United States earlier this year, and more than one million diabetic patients world-wide receive annual retinal risk assessments using Digital Healthcare software. There are approximately 20 million diabetic patients in the United States, but it is estimated that only about half of them get regular retinal risk assessments.

Retasure offers several advantages to primary care physicians and their patients: It can be operated by non-clinicians; it is non-invasive and requires no dilation; it obtains exceptionally high-quality digital images of the retina using a simple-to-operate fundus camera; it returns results quickly to primary care physicians; and it encourages patient compliance for regular retinal assessment.

Digital Healthcare's iP(R) technology platform is an integrated workflow management engine designed to connect and share critical clinical information across primary and secondary care. The system uses ultra-secure communications, high resolution digital imaging, patient, physician and clinic management, standardized assessment, grading and reporting together with patient outcome management.

"FDA approval for Retasure and our iP(R) technology platform marks a major step forward in the development of Digital Healthcare," said Marc Winchester, President, North America and Board Director of Digital Healthcare. "Pre-market approval clears the way for the company to market our products and services more widely.

"The approval not only covers our retinal risk assessment products such as Retasure, but also our next generation clinical ophthalmology technology which effectively integrates most instruments and technologies used in clinics using workflow management tools. These tools will improve both operational efficiency and the outcomes for many patients. Our reach now extends from the detection of eye disease, through diagnosis and patient outcome management."

Digital Healthcare is the global leader in retinal risk assessment. They are the world's leading provider of care management programs for diabetic retinopathy. Their award-winning MS-HUG technology is used by leading hospitals and research centers including Case Western University, The Wilmer Eye Institute at The Johns Hopkins University and the United States Military.


'/>"/>
SOURCE Digital Healthcare Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Oracle Corp. to help build worlds first "Digital Hospital"
2. Digital mammography proves effective
3. Digital Mammogram For Detection Of Breast Cancer In Women With Dense Breasts
4. Research into Blindness Cure Goes Digital
5. Digitalis Could Be Safe In Diastolic Heart Failure
6. MDCT Compared to Digital Radiography in Orthopedic Patients
7. Digital ID Chips Implanted in Dogs to Prevent Rabies
8. Eli Lilly Releases Digital Insulin Pen
9. The Worlds First Digital Insulin Pen With a Memory Launched
10. Interactive Digital Television to Monitor Health
11. Digital Music Project Aims to Save Tibetan Folk Songs from Extinction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2016)... ... 10, 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) ... other healthcare organizations to promote diabetes education at the World Diabetes Day observance. ... of speakers from around the Commonwealth of Pennsylvania. Speakers included Dr. Renu ...
(Date:12/9/2016)... ... December 09, 2016 , ... The American ... audiologists—to remain a critical part of public access to hearing aid technology. , ... announced this week that, starting immediately, it would no longer enforce the ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... folded, pharmaceutical inserts and outserts. As a means of expanding capabilities Flottman ... will enable Flottman to individually code professional inserts (PIs) and patient package inserts ...
(Date:12/9/2016)... Woodland Hills, CA (PRWEB) , ... December 09, ... ... center for young adults, celebrated its 10th anniversary with the grand opening of ... Hills, California. The successful event spanned two days, December 2-3, and was attended ...
(Date:12/9/2016)... ... December 09, 2016 , ... The ... Hotel in New York, NY, on December 3rd, to benefit Holy Name Medical ... the annual event, which raised over $1 million - the largest event in ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... DIEGO , Dec. 9, 2016 aTyr Pharma, Inc. ... discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, ... at the upcoming BMO Prescriptions for Success Healthcare Conference at the ... on Wednesday, December 14, 2016, at 4:20 p.m. ET. ... ...
(Date:12/9/2016)... Department of Health Secretary Dr. Karen ... dispensaries under Act 16 are slated for publication in ... now available online . "The dispensary temporary ... operation; process for dispensing medical marijuana; security and surveillance ... dispensary facilities can be located," said Secretary Murphy. "Our ...
(Date:12/8/2016)... Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... issued shares of common stock, $0.01 par value (the "Offering" ... public offering.  The final terms of the Offering will depend ... and there can be no assurance as to whether or ... to use the net proceeds it will receive from this ...
Breaking Medicine Technology: